Microtubule/Tubulin inhibitor, TRx0237 mesylate, Purity ≥98%

Cat. No.: X24-08-YM244

Microtubule/Tubulin inhibitor, TRx0237 mesylate, Purity ≥98%

Synonym: 1236208-20-0; Leucomethylene blue mesylate; Hydromethylthionine mesylate; Methanesulfonic acid; 3-N,3-N,7-N,7-N-tetramethyl-10H-phenothiazine-3,7-diamine

  • MDL: MFCD29764308
  • CAS Number: 1236208-20-0
  • Compound CID: 60150609
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TRx0237 mesylate, soluble in DMSO and water and insoluble in ethanol, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
477.62
Molecular Formula
C16H19N3S·2CH4O3S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 90 mg/mL (188.43 mM); Water: 90 mg/mL (188.43 mM); Ethanol: insoluble
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
TRx0237 mesylate is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of neurodegenerative diseases such as Alzheimer’s disease by reducing tau-related pathology.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.